Could obesity drugs ease anxiety and depression?
GLP-1 medications are associated with a reduced need for psychiatric hospital care and fewer employee sick days. They also appear to lower the risk of substance use disorders…. read more.
GLP-1 medications are associated with a reduced need for psychiatric hospital care and fewer employee sick days. They also appear to lower the risk of substance use disorders…. read more.
The EU’s drug regulator, the European Medicines Agency (EMA), has issued recommendations for the influenza virus strains that vaccine manufacturers should include from autumn 2026. Every year, EMA… read more.
Eli Lilly and Company announced that Foundayo (orforglipron) is now available to adults with obesity or overweight with weight-related medical problems following the FDA approval on April 1,… read more.
The antidepressant duloxetine does not appear to prevent chemotherapy-associated nerve damage in colorectal cancer. This finding appeared in the JCO Oncology Advances on March 25, 2026 followed by… read more.
Equillium, Inc. (Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new EQ504 preclinical data have been accepted for… read more.
Johnson & Johnson announced that the FDA has approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients… read more.
Cornell University scientists have taken a major step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, considered the holy grail of male contraception. A… read more.
While cigarette exposures are decreasing for young children, electronic nicotine products are putting toddlers at new risk of inhalation, according to Rutgers Health researchers. Their study, published in JAMA Network… read more.
Corcept Therapeutics presented late-breaking data from its MOMENTUM trial examining the prevalence of endogenous hypercortisolism in patients with resistant hypertension at the 2026 American College of Cardiology Annual… read more.
Children with the rare but serious allergic disease FPIES have an atypical gut microbiota compared to healthy children. This is shown in a new study from Umeå University,… read more.
The Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for Kyinsu (insulin icodec + semaglutide, IcoSema) intended… read more.
Taxes on sugary drinks had no effect on beverage calorie purchases from fast-food chain restaurants in the U.S., according to a new study by Brian Elbel and Pasquale… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.